
Sign up to save your podcasts
Or


His plan to reclassify cannabis, so that it's no longer a Schedule I drug under the Controlled Substances Act, wouldn't make pot legal in the U.S., but it could help marijuana companies do more business. What does the research show about marijuana's harms, and does this fit Trump's call to "Make America Healthy Again"?
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Paul Gigot, The Wall Street Journal4.2
27362,736 ratings
His plan to reclassify cannabis, so that it's no longer a Schedule I drug under the Controlled Substances Act, wouldn't make pot legal in the U.S., but it could help marijuana companies do more business. What does the research show about marijuana's harms, and does this fit Trump's call to "Make America Healthy Again"?
Learn more about your ad choices. Visit megaphone.fm/adchoices

1,713 Listeners

4,420 Listeners

1,649 Listeners

1,538 Listeners

5,181 Listeners

4,909 Listeners

686 Listeners

1,448 Listeners

2,039 Listeners

2,835 Listeners

6,097 Listeners

720 Listeners

1,322 Listeners

8,447 Listeners

586 Listeners

151 Listeners

150 Listeners

1,121 Listeners

180 Listeners